NCT04789928 - Conservative Treatment of Catheter - Related Injections With Gentamicine/EDTA | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 5, 2021

Primary Completion Date

December 31, 2023

Study Completion Date

March 1, 2024

Conditions

Patients With Uncomplicated Long-term Central Venous Catheter-related Biofilm-related Infection

Interventions

DRUG

Gentamicins-EDTA

Patients included in this study will receive daily injection (up to 10 days) of genta-EDTA-Na2 lock associated with systemic antibiotics.

Trial Locations (6)

Hôpital Saint-Louis, Paris

Hôpital Cochin, Paris

Hôpital Beaujon, Paris

Centre Hospitalier Intercommunal de Créteil, Créteil

HEGP, Paris

Hôpital Henri Mondor, Paris